Ilex Capital Partners (Uk) LLP Moderna, Inc. Transaction History
Ilex Capital Partners (Uk) LLP
- $2.45 Trillion
- Q1 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 34,147 shares of MRNA stock, worth $896,700. This represents 0.04% of its overall portfolio holdings.
Number of Shares
34,147Holding current value
$896,700% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
871Shares Held
255MCall Options Held
23.9MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$671 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$655 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$467 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$196 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...